Cite
HARVARD Citation
Uzawa, A. et al. (2020). Serum level of soluble urokinase plasminogen activator receptor (suPAR) as a disease severity marker of myasthenia gravis: a pilot study. Clinical and experimental immunology. pp. 321-324. [Online].